REFRACTORY ALVEOLAR RHABDOMYOSARCOMA

Clinical trials for REFRACTORY ALVEOLAR RHABDOMYOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY ALVEOLAR RHABDOMYOSARCOMA trials appear

Sign up with your email to follow new studies for REFRACTORY ALVEOLAR RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with tough cancers: experimental pill enters trial

Disease control Ongoing

This study is testing a new oral drug called Elimusertib in children and young adults whose solid tumors have come back or stopped responding to standard treatments. The main goals are to find the safest dose and see if the drug can shrink tumors, particularly in certain types of…

Matched conditions: REFRACTORY ALVEOLAR RHABDOMYOSARCOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

REFRACTORY ALVEOLAR RHABDOMYOSARCOMA

Get alerted when new REFRACTORY ALVEOLAR RHABDOMYOSARCOMA trials appear

New hope for kids with tough cancers: experimental pill enters trial